SynthesisMedicine2015

The Risk of Neutropenia and Leukopenia in Advanced Non-Small Cell Lung Cancer Patients Treated With Erlotinib: A Prisma-Compliant Systematic Review and Meta-Analysis.

Jian-Guo Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.